Rituximab as Second Line Treatment for ITP

Clinical trial NCT00344149 · COMPLETED

Trial details

NCT number: NCT00344149
Sponsor: Ostfold Hospital Trust
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2006-06-01
Primary completion: 2014-03-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.